← FDA DRUG APPROVALS
FDA NDA · NDA020670
MONISTAT 3 COMBINATION PACK 3 OVULE INSERTS
miconazole nitrate
Sponsor: MEDTECH PRODUCTS
APPLICATION
NDA020670
TYPE
NDA
ORIGINAL APPROVAL
1996-04-16
LATEST ACTION
2023-11-17
ROUTE
TOPICAL, VAGINAL, TOPICAL, VAGINAL
DOSAGE FORM
CREAM, SUPPOSITORY
MARKETING STATUS
Over-the-counter
Products
MONISTAT 3 COMBINATION PACK · ReferenceOver-the-counter
MICONAZOLE NITRATE 2%,200MG · CREAM, SUPPOSITORY · TOPICAL, VAGINAL
Approval history
2016-01-21Manufacturing (CMC) · Supplement 29 · standardAP
2015-11-20Manufacturing (CMC) · Supplement 28 · standardAP
2014-02-11Manufacturing (CMC) · Supplement 24 · standardAP
2013-07-10Manufacturing (CMC) · Supplement 22 · standardAP
2013-02-06Manufacturing (CMC) · Supplement 21 · standardAP
2002-10-28Manufacturing (CMC) · Supplement 10 · standardAP
2000-01-20Manufacturing (CMC) · Supplement 7 · standardAP
1999-10-04Manufacturing (CMC) · Supplement 5 · standardAP
1999-03-26Manufacturing (CMC) · Supplement 4 · standardAP
1998-03-17Manufacturing (CMC) · Supplement 3 · standardAP
1997-03-21Manufacturing (CMC) · Supplement 2 · standardAP
1996-08-15Manufacturing (CMC) · Supplement 1 · standardAP
1996-04-16Type 8 - Partial Rx to OTC Switch · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.